Answer
Yes, Esmya (ulipristal acetate) is contraindicated in patients with an underlying liver disorder.
Sources for this answer
- Esmya 5 mg Tablets (ulipristal acetate)Gedeon Richter (UK) Ltd · emc · SmPC §4.3 Contraindications · Version 13Document updated
Sources checked